A hydrogel-based stem cell delivery system to treat retinal degenerative diseases

Biomaterials

Volumn 31, Issue 9, 2010, Pages 2555-2564

  Ballios, Brian G ^a   Cooke, Michael J ^b   van der Kooy, Derek ^a   Shoichet, Molly S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell spreading; Cell viability; Hyaluronan; Hydrogel; Retina; Stem cell

Indexed keywords

BIOLOGICAL PROPERTIES; CELL DELIVERY; CELL SPREADING; CELL VIABILITY; CELLULAR DELIVERY; HYALURONAN; HYALURONAN HYDROGELS; IN-VITRO; IN-VIVO; METHYLCELLULOSE; PROGENITOR CELL; RETINAL DEGENERATIVE DISEASE; SALINE SOLUTIONS; STEM CELL; TISSUE INTEGRATION; VISCOUS SOLUTION;

BIODEGRADATION; CYTOLOGY; HYDROGELS; OPHTHALMOLOGY;

STEM CELLS;

HYALURONIC ACID; METHYLCELLULOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HYDROGEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA DEGENERATION; STEM CELL TRANSPLANTATION; VISCOSITY;

ANIMALS; BIOCOMPATIBLE MATERIALS; GREEN FLUORESCENT PROTEINS; HYALURONIC ACID; HYDROGEL; METHYLCELLULOSE; MICE; RETINAL DEGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

MUS;

EID: 74449084704     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.12.004     Document Type: Article

References (51)

1. Shintani K., Shechtman D.L., and Gurwood A.S. Review and update: current treatment trends for patients with retinitis pigmentosa. Optometry 80 (2009) 384-401
2. Klein B.E.K. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14 (2007) 179-183
3. Kaufman S.R. Developments in age-related macular degeneration: diagnosis and treatment. Geriatrics 64 (2009) 16-19
4. Congdon N.G., Friedman D.S., and Lietman T. Important causes of visual impairment in the world today. J Am Med Assoc 290 (2003) 2057-2060
5. Lee P., Wang C.C., and Adamis A.P. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43 (1998) 245-269
6. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
7. Menon G., and Walters G. New paradigms in the treatment of wet AMD: the impact of anti-VEGF therapy. Eye 23 Suppl. 1 (2009) S1-S7
8. Comer G.M., and Ciulla T.A. Current and future pharmacological intervention for diabetic retinopathy. Expert Opin Emerg Drugs 10 (2005) 441-455
9. Algvere P.V., Gouras P., and Kopp E.D. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 9 (1999) 217-230
10. Algvere P.V., Berglin L., Gouras P., and Sheng Y. Human fetal RPE transplants in age related macular degeneration (ARMD). Invest Ophthalmol Vis Sci 37 (1996) S96
11. Das T.P., Del Cerro M., Lazar E.S., Jalali S., DiLoreto D.A., Little C.W., et al. Transplantation of neural retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci 37 (1996) S96
12. Chen F.K., Uppal G.S., Maclaren R.E., Coffey P.J., Rubin G.S., Tufail A., et al. Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration. Clin Experiment Ophthalmol 37 (2009) 275-285
13. Da Cruz L., Chen F.K., Ahmado A., Greenwood J., and Coffey P. RPE transplantation and its role in retinal disease. Prog Retin Eye Res 26 (2007) 598-635
14. Berson E.L., and Jakobiec F.A. Neural retinal cell transplantation: ideal versus reality. Ophthalmology 106 (1999) 445-446
15. Klassen H., Sakaguchi D.S., and Young M.J. Stem cells and retinal repair. Prog Retin Eye Res 23 (2004) 149-181
16. Enzmann V., Yolcu E., Kaplan H.J., and Ildstad S.T. Stem cells as tools in regenerative therapy for retinal degeneration. Arch Ophthalmol 127 (2009) 563-571
17. Das A.M., Zhao X., and Ahmad I. Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources. Semin Ophthalmol 20 (2005) 3-10
18. Tropepe V., Coles B.L.K., Chiasson B.J., Horsford D.J., Elia A.J., McInnes R.R., et al. Retinal stem cells in the adult mammalian eye. Science 287 (2000) 2032-2036
19. Coles B.L.K., Angenieux B., Inoue T., Rio-Tsonis K., Spence J.R., McInnes R.R., et al. Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci USA 101 (2004) 15772-15777
20. Sugarman J. Human stem cell ethics: beyond the embryo. Cell Stem Cell 2 (2008) 529-533
21. Kinouchi R., Takeda M., Yang L., Wilhelmsson U., Lundkvist A., Pekny M., et al. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci 6 (2003) 863-868
22. Klassen H.J., Ng T.F., Kurimoto Y., Kirov I., Shatos M., Coffey P., et al. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 45 (2004) 4167-4173
23. Redenti S., Neeley W.L., Rompani S., Saigal S., Yang J., Klassen H., et al. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials 30 (2009) 3405-3414
24. Redenti S., Tao S., Yang J., Gu P., Klassen H., Saigal S., et al. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold. J Ocul Biol Dis Infor 1 (2008) 19-29
25. Neeley W.L., Redenti S., Klassen H., Tao S., Desai T., Young M.J., et al. A microfabricated scaffold for retinal progenitor cell grafting. Biomaterials 29 (2008) 418-426
26. Tao S., Young C., Redenti S., Zhang Y., Klassen H., Desai T., et al. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip 7 (2007) 695-701
27. Tomita M., Lavik E., Klassen H., Zahir T., Langer R., and Young M.J. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells 23 (2005) 1579-1588
28. Lavik E.B., Klassen H., Warfvinge K., Langer R., and Young M.J. Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials 26 (2005) 3187-3196
29. Kubitz J.C., and Motsch J. Eye surgery in the elderly. Best Pract Res Clin Anaesthesiol 17 (2003) 245-257
30. Tschon M., Fini M., Giavaresi G., Torricelli P., Rimondini L., Ambrosio L., et al. In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices. Int J Artif Organs 30 (2007) 352-362
31. Wallace D.G., and Rosenblatt J. Collagen gel systems for sustained delivery and tissue engineering. Adv Drug Deliv Rev 55 (2003) 1631-1649
32. Chenite A., Chaput C., Wang D., Combes C., Buschmann M.D., Hoemann C.D., et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21 (2000) 2155-2161
33. Gupta D., Tator C.H., and Shoichet M.S. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27 (2006) 2370-2379
34. Kang C.E., Poon P.C., Tator C.H., and Shoichet M.S. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair. Tissue Eng Part A 15 (2009) 595-604
35. Baumann M.D., Kang C.E., Stanwick J.C., Wang Y., Kim H., Lapitsky Y., et al. An injectable drug delivery platform for sustained combination therapy. J Control Release 138 (2009) 205-213
36. Shoichet M.S., Tator C.H., Poon P., Kang C., and Douglas Baumann M. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord. Prog Brain Res 161 (2007) 385-392
37. Balazs E.A. Medical applications of hyaluronan and its derivatives. J Polym Mater Sci Eng 63 (1990) 689-691
38. Balazs E.A., Bland P.A., Denlinger J.L., Goldman A.I., Larsen N.E., Leshchiner E.A., et al. Matrix engineering. Blood Coagul Fibrinolysis 2 (1991) 173-178
39. Vercruysse K.P., Prestwich G.D., and Kuo J.W. Hyaluronate derivatives in drug delivery. Crit Rev Ther Drug Carrier Syst 15 (1998) 513-555
40. Hollyfield J.G. Hyaluronan and the functional organization of the interphotoreceptor matrix. Invest Ophthalmol Vis Sci 40 (1999) 2767-2769
41. Hollyfield J.G., Rayborn M.E., Tammi M., and Tammi R. Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation. Exp Eye Res 66 (1998) 241-248
42. Coles B.L.K., Horsford D.J., McInnes R.R., and Van Der Kooy D. Loss of retinal progenitor cells leads to an increase in the retinal stem cell population in vivo. Eur J Neurosci 23 (2006) 75-82
43. Xu H., Iglesia D.D., Kielczewski J.L., Valenta D.F., Pease M.E., Zack D.J., et al. Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes. Invest Ophthalmol Vis Sci 48 (2007) 1674-1682
44. Mori H., Fujitani T., Kanemura Y., Kino-oka M., and Taya M. Observational examination of aggregation and migration during early phase of neurosphere culture of mouse neural stem cells. J Biosci Bioeng 104 (2007) 231-234
45. Hogg R.E., and Chakravarthy U. Visual function and dysfunction in early and late age-related maculopathy. Prog Retin Eye Res 25 (2006) 249-276
46. Tucker B.A., Redenti S., Jiang C., Swift J., Klassen H., Smith M., et al. The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation. Biomaterials 31 (2010) 9-19
47. Schwartz D.M., Shuster S., Jumper M.D., Chang A., and Stern R. Human vitreous hyaluronidase: isolation and characterization. Curr Eye Res 15 (1996) 1156-1162
48. Hayasaka S., Shiono T., Hara S., and Mizuno K. Lysosomal hyaluronidase in the subretinal fluid of patients with rhegmatogenous retinal detachments. Am J Ophthalmol 94 (1982) 58-63
49. Arden G.B., Sidman R.L., Arap W., and Schlingemann R.O. Spare the rod and spoil the eye. Br J Ophthalmol 89 (2005) 764-769
50. Elizabeth Rakoczy P., Yu M.J.T., Nusinowitz S., Chang B., and Heckenlively J.R. Mouse models of age-related macular degeneration. Exp Eye Res 82 (2006) 741-752
51. Ding X., Patel M., and Chan C.C. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res 28 (2009) 1-18